-
公开(公告)号:EP2364089A1
公开(公告)日:2011-09-14
申请号:EP09823937.9
申请日:2009-10-30
申请人: Biogen Idec MA Inc.
发明人: GUCKIAN, Kevin, M. , CALDWELL, Richard, D. , KUMARAVEL, Gnanasambandam , LEE, Wen-cherng , LIN, Edward, Yin-shiang , LIU, Xiaogao , MA, Bin , SCOTT, Daniel, M. , SHI, Zhan , ZHENG, Guo, Zhu , TAVERAS, Arthur, G. , THOMAS, Jermaine
IPC分类号: A01N47/10 , A61K31/22 , A61K31/135
CPC分类号: A61K31/135 , A61K31/22 , C07C217/52 , C07C217/74 , C07C2602/10 , C07D215/20 , C07D239/74
摘要: Compounds that have agonist activity at one or more of the SlP receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at SlP receptors.
-
公开(公告)号:EP2364088B1
公开(公告)日:2014-04-16
申请号:EP09823936.1
申请日:2009-10-30
申请人: Biogen Idec MA Inc.
发明人: GUCKIAN, Kevin, M. , CALDWELL, Richard, D. , KUMARAVEL, Gnanasambandam , LEE, Wen-cherng , LIN, Edward, Yin-shiang , LIU, Xiaogao , MA, Bin , SCOTT, Daniel, M. , SHI, Zhan , ZHENG, Guo, Zhu , TAVERAS, Arthur, G. , THOMAS, Jermaine
IPC分类号: C07C271/16 , C07F9/653 , C07C205/26 , C07C205/50 , C07C217/52 , C07C217/60 , C07C229/32 , C07D263/38 , C07C215/10 , C07C215/08 , C07F9/09 , A01N47/10 , A61K31/135 , A61K31/27 , A61P11/06 , A61P29/00 , A61P17/06 , A61P19/02
CPC分类号: A61K31/135 , A61K31/27 , C07C205/26 , C07C205/50 , C07C217/52 , C07C217/60 , C07C229/32 , C07C271/16 , C07D263/38 , C07F9/091 , C07F9/093 , C07F9/653 , C07F9/65744
-
公开(公告)号:EP2364088A1
公开(公告)日:2011-09-14
申请号:EP09823936.1
申请日:2009-10-30
申请人: Biogen Idec MA Inc.
发明人: GUCKIAN, Kevin, M. , CALDWELL, Richard, D. , KUMARAVEL, Gnanasambandam , LEE, Wen-cherng , LIN, Edward, Yin-shiang , LIU, Xiaogao , MA, Bin , SCOTT, Daniel, M. , SHI, Zhan , ZHENG, Guo, Zhu , TAVERAS, Arthur, G. , THOMAS, Jermaine
IPC分类号: A01N47/10 , A61K31/27 , A61K31/135
CPC分类号: A61K31/135 , A61K31/27 , C07C205/26 , C07C205/50 , C07C217/52 , C07C217/60 , C07C229/32 , C07C271/16 , C07D263/38 , C07F9/091 , C07F9/093 , C07F9/653 , C07F9/65744
摘要: Compounds that have agonist activity at one or more of the SlP receptors are provided. The compounds are sphingosine analogs that, after phosphorylation, can behave as agonists at S lP receptors.
-
-